An ostomy also known as bowel diversion is a surgical procedure that involves the removal of diseased portions of the gastrointestinal or urinary system and creation of an artificial opening in the abdomen to allow for the elimination of body wastes. An ostomy is considered as essential procedure in various conditions including Colorectal cancer, bladder cancer, Crohn’s disease, ulcerative colitis, birth defects, and other intestinal or urinary medical condition etc. Some of the major factors that are identified during the study which are expected to propel the growth of market are increasing cases of ostomies among the old age population, growth in rate of the incidence of gastrointestinal diseases worldwide, advancement in technology, and innovation of new products and techniques related to the procedure. However, complications associated with use of ostomy systems are expected to hamper the growth of market during the forecast period.
Valuing at USD 1989.50 million, the market for ostomy care system is anticipated to grow at a pace of 4.22% over the forecast period. The increasing demand for one-piece, two-piece system and skin barriers is anticipated to fuel the market over the forecast period. Technological advancements in ostomy products should boost their demand. The manufacturing companies have adopted advanced technology, and integration of such technology has enabled ease of usage of ostomy products that will drive industry growth.
The oncology segment held the largest market share of the enteral feeding formula, primarily due to high prevalence of malnutrition among cancer patients. Cancer patients are prone to severe malnutrition induced by the tumour or its associated therapy including tumour removal surgeries, radiations and chemotherapy which in turn surge the demand for tube feeding for nutritional support.
Europe has been dominating the global ostomy care market and is expected to maintain its dominant position over the forecast period. Increasing risk of ulcerative colitis and colorectal cancer in the geriatric populace and growing awareness for stoma surgeries are factors attributed to support to the dominance of Europe in the global ostomy care market.
In 2019, homecare accounted for the major market share and it is also expected to be one of the fastest growing in over forecast period. Increase in demand for home healthcare is expected to drive this segment. Home care settings offers proper care to a patient, which significantly reduces the risk of ostomy-related complications, thereby reducing emergency visits to hospitals.
The key competitors of this market include Coloplast A/S (Denmark), B Braun (Germany), Alcare Ltd. (Japan), Convatec Group (UK), Prowess Care (India), Hollister Incorporated (U.S.), Salts Healthcare Ltd (UK), Cymed (U.S.), Flexicare (UK), Perma-type Company Inc. (U.S.), 3M (U.S.), Marlen Manufacturing & Development Company (U.S.), Smith & Nephew (U.K.), Schena Ostomy Technologies (U.K.), Nu-hope Laboratories (U.S.), and Welland Medical Limited (U.K.) among others.